Both in Diagnostics
Neogen vs Achieve Life Sciences
Over the past year NEOG returned +91.6% and ACHV returned +33.4%; their daily moves had a correlation of 0.12.
NEOG +91.6% ACHV +33.4%Growth of $1, one year, split-adjusted
| Metric | NEOG | ACHV |
|---|---|---|
| Price | $11.82 | $6.83 |
| Market cap | $2.58B | $704.2M |
| Today | −3.59% | −5.01% |
| 1 month | −3.4% | −9.3% |
| 6 months | +24.0% | +55.9% |
| Year to date | +69.1% | +37.4% |
| 1 year | +89.7% | +38.0% |
| Revenue growth (YoY) | +6.5% | — |
| Gross margin | 47.4% | — |
| Net margin | −5.3% | — |
| P/E (TTM) | — | — |
| Price / sales | 2.9× | — |
| Net cash | -$605.6M | $172.4M |
| Dividend yield | — | — |
| Volatility (60d) | 41.7% | 59.7% |
| Short % of float | 5.5% | 28.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).